Ads
related to: tb treatment and liver damage symptoms cirrhosis- About NASH
Learn more about the consequences
of NASH and patient management.
- NASH Identification
Find more on the identification
and monitoring.
- Sign Up For Updates
Stay informed on the latest
NASH news and information.
- NASH With Fibrosis
Learn about the basics of NASH
on the official HCP website.
- About NASH
Search results
Results from the WOW.Com Content Network
Management of tuberculosis refers to techniques and procedures utilized for treating tuberculosis (TB), or simply a treatment plan for TB. The medical standard for active TB is a short course treatment involving a combination of isoniazid , rifampicin (also known as Rifampin), pyrazinamide , and ethambutol for the first two months.
Tuberculosis (TB), also known colloquially as the "white death", or historically as consumption, [7] is a contagious disease usually caused by Mycobacterium tuberculosis (MTB) bacteria. [1] Tuberculosis generally affects the lungs , but it can also affect other parts of the body. [ 1 ]
Cirrhosis, also known as liver cirrhosis or hepatic cirrhosis, chronic liver failure or chronic hepatic failure and end-stage liver disease, is a condition of the liver in which the normal functioning tissue, or parenchyma, is replaced with scar tissue and regenerative nodules as a result of chronic liver disease.
In the developed world, the most common cause is liver cirrhosis. [4] Other causes include cancer, heart failure, tuberculosis, pancreatitis, and blockage of the hepatic vein. [4] In cirrhosis, the underlying mechanism involves high blood pressure in the portal system and dysfunction of blood vessels. [4]
Drug-induced liver injury (DILI) is a cause of acute and chronic liver disease caused specifically by medications and the most common reason for a drug to be withdrawn from the market after approval. The liver plays a central role in transforming and clearing chemicals and is susceptible to the toxicity from these agents.
Hepatic hydrothorax is a rare form of pleural effusion that occurs in people with liver cirrhosis. It is defined as an effusion of over 500 mL in people with liver cirrhosis that is not caused by heart, lung, or pleural disease. It is found in 5–10% of people with liver cirrhosis and 2–3% of people with pleural effusions.
Ads
related to: tb treatment and liver damage symptoms cirrhosis